Clinical Trial Update: Brain Network Dynamics of Depression During Esketamine Treatment

View source ↗

Summary

The clinical trial evaluating brain network dynamics during esketamine treatment for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Spravato (esketamine) (esketamine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Depressive Disorder, Major | Status: COMPLETED